Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 146.18 USD | +6.45% |
|
+5.44% | +67.37% |
| Market Cap | 9.4B 8.16B 7.64B 6.99B 13.19B 896B 13.36B 89.37B 35.07B 447B 35.3B 34.53B 1,489B | P/E 2026 * |
30.9x | P/E 2027 * | -259x |
|---|---|---|---|---|---|
| Enterprise Value | 8.83B 7.66B 7.17B 6.56B 12.39B 841B 12.55B 83.91B 32.93B 420B 33.14B 32.42B 1,398B | EV / Sales 2026 * |
16.3x | EV / Sales 2027 * | 44.2x |
| Free-Float |
97.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | +6.45% | ||
| 1 week | +5.44% | ||
| Current month | +6.98% | ||
| 1 month | +11.16% | ||
| 3 months | +40.60% | ||
| 6 months | +73.01% | ||
| Current year | +67.37% |
| 1 week | 131.68 |  | 148 |
| 1 month | 125.32 | | 148 |
| Current year | 77 | | 148 |
| 1 year | 50.48 | | 148 |
| 3 years | 13.72 | | 148 |
| 5 years | 6.91 | | 148 |
| 10 years | 4.47 | | 148 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/06/26 | Fiscal year | Director | 27,000 | 0.0420% | ||
| 17/02/26 | Fiscal year | Director | 54,000 | 0.0864% | ||
| 06/02/26 | Fiscal year | Director | 60,000 | 0.0960% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.45% | +5.44% | +171.38% | +662.15% | 9.4B | |
| +0.93% | -0.63% | +3.89% | +14.93% | 48.7B | |
| +0.26% | +2.93% | +439.43% | +533.80% | 42.05B | |
| -1.53% | -2.25% | +30.95% | +7.15% | 38.26B | |
| +0.69% | +2.40% | +10.48% | +63.05% | 37.5B | |
| +2.47% | +2.63% | +14.71% | +48.37% | 31.44B | |
| -0.47% | +1.16% | +35.93% | +126.09% | 16.33B | |
| +2.31% | -0.49% | - | - | 16.47B | |
| +0.29% | +1.87% | +8.17% | +18.60% | 13.98B | |
| -1.43% | -2.63% | +3.70% | -36.38% | 12.43B | |
| Average | +1.00% | +0.82% | +79.85% | +159.75% | 26.66B | |
| Weighted average by Cap. | +0.67% | +0.44% | +92.23% | +141.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 542M 471M 441M 403M 761M 51.67B 771M 5.16B 2.02B 25.82B 2.04B 1.99B 85.93B | 200M 174M 163M 149M 281M 19.06B 284M 1.9B 746M 9.52B 751M 735M 31.7B |
| Net income | 319M 276M 259M 237M 447M 30.35B 453M 3.03B 1.19B 15.16B 1.2B 1.17B 50.47B | -34.19M -29.67M -27.78M -25.41M -47.97M -3.26B -48.6M -325M -128M -1.63B -128M -126M -5.42B |
| Net Debt | -574M -498M -466M -427M -805M -54.67B -816M -5.46B -2.14B -27.32B -2.15B -2.11B -90.92B | -565M -490M -459M -420M -792M -53.8B -803M -5.37B -2.11B -26.88B -2.12B -2.07B -89.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | US$146.18 | +6.45% | 837,613 |
| 05/08/26 | US$137.32 | +1.11% | 430,528 |
| 04/08/26 | US$135.81 | +2.67% | 634,672 |
| 03/08/26 | US$132.28 | -3.19% | 451,166 |
| 31/07/26 | US$136.64 | -1.44% | 548,764 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
